What is Neuropace, Inc.'s price / sales?

Neuropace, Inc. (NPCE) reported price / sales of 4.4× in Q1 2026.

How has Neuropace, Inc.'s price / sales changed year-over-year?

Neuropace, Inc.'s price / sales decreased by 6.3% year-over-year, from 4.7× to 4.4×.

What is the long-term trend for Neuropace, Inc.'s price / sales?

Over 4 years (2021 to 2025), Neuropace, Inc.'s price / sales has grown at a -1.3% compound annual growth rate (CAGR), from 5.4× to 5.1×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Neuropace, Inc. NPCE Price / sales

Price / sales at other companies

MedtronicMDT

2.9×-0.4×

LivaNovaLIVN

2.4×+0.8×

ClearPoint NeuroCLPT

6.6×-3.5×

Inspire Medical SystemsINSP

1.6×-4.0×

ARS Pharmaceuticals, Inc.SPRY

8.1×-4.7×

Catalyst PharmaceuticalCPRX

5.1×-0.4×

Other financials

Income statement

See full

Revenue$22.1M-2.0%

Gross profit$18.0M+4.1%

Operating income-$5.6M-8.2%

Net income-$6.7M-1.5%

EPS (diluted)-$0.20+4.8%

Balance sheet

See full

Cash & equivalents$15.6M-42.4%

Total debt$70.5M-3.7%

Total equity$14.5M-40.4%

Total assets$98.9M-10.3%

Cash flow

See full

Operating cash flow-$5.9M+21.1%

CapEx$117.0K+216%

Free cash flow-$6.0M+20.0%

Valuation

See full

Market cap$557.77M+63.4%

Enterprise value$612.6M+58.1%

Profitability

See full

Gross margin78.3%+3.5pp

Operating margin-16.8%-3.5pp

Net margin-21.7%-4.5pp

FCF margin-10.3%-3.5pp

Returns & leverage

See full

Return on equity-111.4%-13.1pp

Debt / equity4.9×+1.9×

Current ratio5.4×-1.2×

Where this comes from

Calculated from Neuropace, Inc.’s reported figures.

market cap/total revenue=4.4×

Based on the most recent quarter.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neuropace, Inc.'s price / sales?: Neuropace, Inc. (NPCE) reported price / sales of 4.4× in Q1 2026.
How has Neuropace, Inc.'s price / sales changed year-over-year?: Neuropace, Inc.'s price / sales decreased by 6.3% year-over-year, from 4.7× to 4.4×.
What is the long-term trend for Neuropace, Inc.'s price / sales?: Over 4 years (2021 to 2025), Neuropace, Inc.'s price / sales has grown at a -1.3% compound annual growth rate (CAGR), from 5.4× to 5.1×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.